Authors : Kale, Ashok; Phadke, Anant
Published Year: 1998
Our argument in brief - The annual cost of hepatitis B immunization of all the newborns alone in India would be Rs. 250 crores, whereas the budget for TB control in India this year is only Rs. 105 crores. Given such a high cost, all options to reduce the cost of Hepatitis -B immunization need to be seriously considered in detail. This cost can be reduced to one-fifth if intradermal route is used. Majority of the published studies show that i.d. route is as effective as i.m./s.c. route and that acceptability by the people is not a problem.